Get startedLog in
    Picture of Caplin Point Laboratories logo

    CAPLIPOINT — Caplin Point Laboratories Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Caplin Point Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,1363,8584,5145,6446,768
    Depreciation
    Non-Cash Items-139-165-332-510-605
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-709-795-1,918-2,484-2,499
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities2,6583,3682,7143,1844,324
    Capital Expenditures-705-912-1,935-1,458-1,915
    Purchase of Fixed Assets
    Other Investing Cash Flow Items651-1,798-241-1,742-1,432
    Sale of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-53.6-2,709-2,176-3,200-3,347
    Financing Cash Flow Items-15.4-14.6-7.8-7.8-6.1
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-240-407-282-381-383
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2,362250268-389608